Elbasvir is a drug approved by the FDA in January 2016 for the treatment of hepatitis C. It was developed by Merck and completed Phase III trials, used...
7 KB (492 words) - 07:51, 17 November 2023
Elbasvir/grazoprevir, sold under the brand name Zepatier, is a fixed-dose combination for the treatment of hepatitis C, containing elbasvir (an inhibitor...
20 KB (1,817 words) - 05:19, 7 April 2024
a number of pharmaceutical drugs including, for example, apararenone, elbasvir, and etifoxine. Polybenzoxazines, also called benzoxazine resins, are a...
2 KB (210 words) - 09:52, 2 July 2024
or 12 weeks of elbasvir/grazoprevir, ledipasvir/sofosbuvir, or sofosbuvir/velpatasvir. An alternative treatment regimen of elbasvir/grazoprevir with...
108 KB (11,833 words) - 07:05, 12 August 2024
Asunaprevir J05AP07 Daclatasvir J05AP08 Sofosbuvir J05AP09 Dasabuvir J05AP10 Elbasvir J05AP11 Grazoprevir J05AP12 Coblopasvir J05AP13 Ravidasvir J05AP51 Sofosbuvir...
6 KB (538 words) - 04:59, 18 December 2023
trials, used in combination with the NS5A replication complex inhibitor elbasvir under the trade name Zepatier, either with or without ribavirin. Grazoprevir...
9 KB (645 words) - 00:06, 19 June 2024
velpatasvir) Vosevi (sofosbuvir, velpatasvir, and voxilaprevir) Zepatier (elbasvir and grazoprevir) Mavyret (glecaprevir and pibrentasvir) The United States...
55 KB (6,733 words) - 06:43, 13 June 2024
Vedroprevir§ Voxilaprevir NS5A inhibitors (–asvir) Coblopasvir Daclatasvir# Elbasvir Ledipasvir Odalasvir† Ombitasvir Pibrentasvir Ravidasvir† Ruzasvir† Samatasvir†...
26 KB (2,541 words) - 05:04, 4 January 2024
Drug Manufacturer Indication Elbasvir/grazoprevir Merck Sharp & Dohme Hepatitis C Palbociclib Pfizer HR-positive, HER2-negative breast cancer Crizotinib...
34 KB (180 words) - 22:09, 8 April 2024
individuals with HIV/HCV co-infection as those with HCV mono-infection: Elbasvir/Grazoprevir The Phase 3, open-label, single-arm C-EDGE CO-INFECTION Study...
28 KB (3,543 words) - 11:12, 31 July 2024